Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 10

The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells

Total article views   Abstract views HTML views PDF downloads Totals
3,276 Dovepress* 2,506 566+ 431 3,072
PubMed Central* 0 204 59 204
Totals 2,506 770 490 3,276
*Since 9 October 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 1 0 1

View citations on PubMed Central and Google Scholar